Majewski H, HEDLER L, Starke K
Naunyn Schmiedebergs Arch Pharmacol. 1982; 321(1):20-7.
PMID: 7144924
DOI: 10.1007/BF00586343.
Ebner F
Naunyn Schmiedebergs Arch Pharmacol. 1981; 316(2):96-107.
PMID: 6264333
DOI: 10.1007/BF00505301.
Gillespie J, Hamilton D, Hosie J
J Physiol. 1970; 206(3):563-90.
PMID: 5498506
PMC: 1348666.
DOI: 10.1113/jphysiol.1970.sp009031.
MARMO E
Arch Kreislaufforsch. 1969; 59(3):325-50.
PMID: 5405509
Farmer J, Kennedy I, Levy G, Marshall R
Br J Pharmacol. 1972; 45(4):660-75.
PMID: 4404413
PMC: 1665961.
DOI: 10.1111/j.1476-5381.1972.tb08125.x.
Role of adrenergic neurone blockade in the hypotensive action of propranolol.
Eliash S, Weinstock M
Br J Pharmacol. 1971; 43(2):287-94.
PMID: 4400571
PMC: 1665837.
The influence of 1-(o-allylphenoxy)-3-isopropylamino-2-propanol hydrochloride (alprenolol) on the central nervous system of the rat.
Herman Z, Drybanski A, Sokola A, Trzeciak H, Chrusciel T
Psychopharmacologia. 1971; 21(1):66-73.
PMID: 4398073
DOI: 10.1007/BF00403997.
Comparative chronotropic activity of beta-adrenoceptive antagonists.
Barrett A, Carter J
Br J Pharmacol. 1970; 40(3):373-81.
PMID: 4395742
PMC: 1703170.
DOI: 10.1111/j.1476-5381.1970.tb10619.x.
Prejunctional actions of some beta-adrenoreceptor antagonists in the vas deferens preparation of the guinea-pig.
Mylecharane E, RAPER C
Br J Pharmacol. 1970; 39(1):128-38.
PMID: 4392958
PMC: 1703050.
DOI: 10.1111/j.1476-5381.1970.tb09562.x.
A comparison of the anti-arrhythmic actions of I.C.I. 50172 and (--)-propranolol and their effects on intracellular cardiac action potentials and other features of cardiac function.
Papp J, Williams E
Br J Pharmacol. 1969; 37(2):391-9.
PMID: 4390670
PMC: 1703656.
DOI: 10.1111/j.1476-5381.1969.tb10576.x.
The effects of acute administration of propranolol and practolol on the uptake, content, release, and turnover of noradrenaline in the rat heart in vivo.
Lemmer B, Saller R
Naunyn Schmiedebergs Arch Pharmacol. 1974; 282(1):85-96.
PMID: 4275629
DOI: 10.1007/BF00647405.
Propranolol inhibits nonexocytotic noradrenaline release in myocardial ischemia.
Richardt G, Lumpp U, Haass M, Schomig A
Naunyn Schmiedebergs Arch Pharmacol. 1990; 341(1-2):50-5.
PMID: 2314483
DOI: 10.1007/BF00195057.
Concentration of (+/-)-propranolol in isolated, perfused lungs of rat.
Dollery C, Junod A
Br J Pharmacol. 1976; 57(1):67-71.
PMID: 1276542
PMC: 1667016.
DOI: 10.1111/j.1476-5381.1976.tb07657.x.
Effect of labetalol on the uptake of [3H]-(-)-noradrenaline into the isolated vas deferens of the rat.
Drew G, Hilditch A, Levy G
Br J Pharmacol. 1978; 63(3):471-4.
PMID: 667491
PMC: 1668086.
DOI: 10.1111/j.1476-5381.1978.tb07799.x.
The binding of [3H]-noradrenaline and [14C]-propranolol to synaptosomal fractions of rat brain homogenates [proceedings].
Hemsworth B, Street J
Br J Pharmacol. 1979; 67(3):497P-498P.
PMID: 497606
PMC: 2044027.
The effect of propranolol on vascular responses to sympathetic nerve stimulation.
Dawes P, Faulkner D
Br J Pharmacol. 1975; 53(4):517-24.
PMID: 238703
PMC: 1666330.
DOI: 10.1111/j.1476-5381.1975.tb07389.x.
Smoking and catecholamine and c-AMP concentrations in the coronary circulation of man and the effect of oxprenolol.
Robson R, Fluck D
Eur J Clin Pharmacol. 1977; 12(2):81-7.
PMID: 200436
DOI: 10.1007/BF00645126.
Beta-adrenoceptors in the human dorsal hand vein, and the effects of propranolol and practolol on venous sensitivity to noradrenaline.
White C, Udwadia B
Br J Clin Pharmacol. 1975; 2(2):99-105.
PMID: 186090
PMC: 1402521.
DOI: 10.1111/j.1365-2125.1975.tb01564.x.
Effects of beta-adrenoreceptor blocking drugs on adrenergic transmission.
Rand M, Law M, Story D, McCulloch M
Drugs. 1976; 11 SUPPL 1:134-43.
PMID: 6246
DOI: 10.2165/00003495-197600111-00029.